3 Diversified FMCG Conglomerate, Laminated Tubes Maker and Diagnostics Chain Stocks With a Strong Future Roadmap: ITC, EPL and Vijaya Diagnostic Centre
- November 5, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
ITC, EPL and Vijaya Diagnostic Centre: ROE of 13.6% to 28.5% and FY22 to FY26 revenue CAGR of 6.8% to 15.1%. Prices as of 4 Nov 2026.
Quick Answer
The three FMCG, tube packaging and diagnostics stocks to watch are ITC, EPL and Vijaya Diagnostic Centre. Their return on equity ranges from 13.6% to 28.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 6.8% to 15.1%. ITC has the highest return on equity at 28.5%, while Vijaya Diagnostic Centre has the fastest revenue growth at 15.1% a year. Prices are based on the 4 November 2026 close, and this article is educational, not investment advice.
FMCG, tube packaging and diagnostics stocks offer a focused view of a sector where demand keeps widening. ITC, EPL and Vijaya Diagnostic Centre cover a diversified FMCG conglomerate, a laminated tubes maker and a diagnostics chain.
This list covers three FMCG, tube packaging and diagnostics stocks with complete current figures: ITC, EPL and Vijaya Diagnostic Centre. Every figure comes from the latest reported financials and the 4 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are FMCG, Tube Packaging and Diagnostics Stocks?
FMCG, tube packaging and diagnostics stocks are listed companies that sell cigarettes, packaged foods and personal care products, make laminated plastic tubes for toothpaste and cosmetics brands, and run diagnostic centres with pathology and radiology services. Their earnings depend on household spending, packaged goods volumes and test volumes.
FMCG, Tube Packaging and Diagnostics Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| ITC | 280 | 322,321 | 16.0 | 32.6 | 28.5 | 0.03 |
| EPL | 223.99 | 7,244 | 18.4 | 21.7 | 13.6 | 0.34 |
| Vijaya Diagnostic Centre | 1,424.6 | 14,066 | 75.0 | 59.6 | 18.1 | 0.44 |
On valuation, ITC and EPL trade at a P/E below the industry P/E, while Vijaya Diagnostic Centre trades above it, which reflects the growth the market already expects. Readers comparing FMCG, tube packaging and diagnostics stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in FMCG, tube packaging and diagnostics stocks can use the coming numbers to test whether growth is holding.
Why Do FMCG, Tube Packaging and Diagnostics Stocks Have a Strong Roadmap in India?
FMCG, tube packaging and diagnostics stocks have a strong roadmap in India because steady household spending, wider use of branded packaging and growing health testing keep widening the market for these companies.
- Diversified FMCG. Households buy trusted food and care brands.
- Tube packaging. Consumer brands need premium tubes.
- Diagnostics. More people take regular tests.
Why ITC Features Among These FMCG, Tube Packaging and Diagnostics Stocks
Among the FMCG, tube packaging and diagnostics stocks on this list, ITC is a diversified Indian company with leading businesses in cigarettes, packaged foods, personal care, paperboards, hotels and agri products, and it sells to consumers across the country.
The company has a return on equity of 28.5%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 322,321 crore. The stock trades at a P/E of 16.0, below the industry P/E of 32.6.
Revenue rose from Rs 62,504 crore in FY22 to Rs 81,294 crore in FY26, a compound annual growth rate of 6.8%. Net profit grew from Rs 15,503 crore in FY22 to Rs 21,018 crore in FY26, which works out to a compound annual growth rate of 7.9%. In the June 2026 quarter, revenue grew 26.7% year on year to Rs 30,179 crore.
Roadmap: The company is growing its packaged foods and personal care brands and expanding its hotels and paper businesses, which broadens its earnings base. Strong cash generation supports investment and shareholder payouts.
What to watch: Follow growth in the foods business, cigarette volumes and progress in newer consumer categories.
Why EPL Features Among These FMCG, Tube Packaging and Diagnostics Stocks
Among the consumer, packaging and health shares on this list, EPL is among the world’s largest makers of laminated plastic tubes used for toothpaste, beauty, personal care and pharmaceutical products. It operates plants across Asia, Europe, the Americas and Africa.
Revenue rose from Rs 3,445 crore in FY22 to Rs 4,806 crore in FY26, a compound annual growth rate of 8.7%. Net profit grew from Rs 221 crore in FY22 to Rs 394 crore in FY26, which works out to a compound annual growth rate of 15.5%.
In the June 2026 quarter, revenue grew 24.7% year on year to Rs 1,392 crore. The company has a return on equity of 13.6%, a debt to equity ratio of 0.34 and a market capitalisation of Rs 7,244 crore. The stock trades at a P/E of 18.4, below the industry P/E of 21.7.
Roadmap: The company is growing sustainable tube formats such as recyclable tubes, which global brands increasingly prefer. A wide plant network lets it serve large customers in many regions.
What to watch: Track the share of sustainable tubes in sales and volume growth in beauty and personal care.
Why Vijaya Diagnostic Centre Features Among These FMCG, Tube Packaging and Diagnostics Stocks
Among the three companies on this list, Vijaya Diagnostic Centre is a Hyderabad-headquartered diagnostics chain that offers pathology and radiology services through a network of centres, with Hyderabad and Telangana as its home base.
In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%.
Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P/E of 75.0, above the industry P/E of 59.6.
Roadmap: The plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.
What to watch: Check the revenue contribution from newer regions and the pace at which new centres turn profitable.
ITC vs EPL vs Vijaya Diagnostic Centre on Key Financials
The table below sets the three FMCG, tube packaging and diagnostics stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| ITC | 62,504 | 81,294 | 6.8% | 21,018 | 25.9% |
| EPL | 3,445 | 4,806 | 8.7% | 394 | 8.2% |
| Vijaya Diagnostic Centre | 475 | 835 | 15.1% | 173 | 20.7% |
ITC posts the highest return on equity in this group at 28.5%. ITC has the largest FY26 revenue at Rs 81,294 crore, and Vijaya Diagnostic Centre shows the fastest revenue growth with a 15.1% compound annual rate. A useful habit with FMCG, tube packaging and diagnostics stocks is to check each new quarterly result against the capacity plans the company described earlier.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| ITC | 23,812 | 30,179 | 26.7% |
| EPL | 1,116 | 1,392 | 24.7% |
| Vijaya Diagnostic Centre | 195 | 240 | 22.8% |
Key Risks to Check Before Investing in FMCG, Tube Packaging and Diagnostics Stocks
Every theme carries risks that deserve a check before any decision. For these FMCG, tube packaging and diagnostics stocks, the main points are: Long-term consumer, packaging and health shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Consumer spending. Sales follow festivals, incomes and consumer mood.
- Test volumes. Footfall and test mix can vary with seasons.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter FMCG, tube packaging and diagnostics stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on FMCG, Tube Packaging and Diagnostics Stocks
FMCG, tube packaging and diagnostics stocks reward patient research into demand, execution and financial strength. ITC, EPL and Vijaya Diagnostic Centre each have a clear plan to grow. Based on the 4 November 2026 close, ITC trades at Rs 280, EPL at Rs 223.99 and Vijaya Diagnostic Centre at Rs 1,424.6. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these FMCG, tube packaging and diagnostics stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track FMCG, tube packaging and diagnostics stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are FMCG, tube packaging and diagnostics stocks?
Ans. FMCG, tube packaging and diagnostics stocks are listed companies that sell cigarettes, packaged foods and personal care products, make laminated plastic tubes for toothpaste and cosmetics brands, and run diagnostic centres with pathology and radiology services. Their earnings depend on household spending, packaged goods volumes and test volumes. This list looks at three of them, ITC, EPL and Vijaya Diagnostic Centre, using reported FY22 to FY26 financials and the 4 November 2026 closing prices.
Which FMCG, tube packaging and diagnostics stocks are covered in this list?
Ans. This list covers ITC, EPL and Vijaya Diagnostic Centre. Based on the 4 November 2026 close, ITC traded at Rs 280, EPL at Rs 223.99 and Vijaya Diagnostic Centre at Rs 1,424.6. Their return on equity ranges from 13.6% to 28.5%, and their revenue compound annual growth from FY22 to FY26 ranges from 6.8% to 15.1%.
Why do FMCG, tube packaging and diagnostics stocks have a strong future roadmap in India?
Ans. FMCG, tube packaging and diagnostics stocks have a strong roadmap in India because steady household spending, wider use of branded packaging and growing health testing keep widening the market for these companies. The main drivers are as follows. Diversified FMCG. Households buy trusted food and care brands. Tube packaging. Consumer brands need premium tubes. Diagnostics. More people take regular tests. Together these factors give the companies on this list a visible path for growth over the coming years.
How has ITC performed financially?
Ans. Revenue rose from Rs 62,504 crore in FY22 to Rs 81,294 crore in FY26, a compound annual growth rate of 6.8%. Net profit grew from Rs 15,503 crore in FY22 to Rs 21,018 crore in FY26, which works out to a compound annual growth rate of 7.9%. In the June 2026 quarter, revenue grew 26.7% year on year to Rs 30,179 crore. The company has a return on equity of 28.5%, a debt to equity ratio of 0.03 and a market capitalisation of Rs 322,321 crore. The stock trades at a P/E of 16.0, below the industry P/E of 32.6. Looking ahead, the company is growing its packaged foods and personal care brands and expanding its hotels and paper businesses, which broadens its earnings base. Strong cash generation supports investment and shareholder payouts.
How has EPL performed financially?
Ans. Revenue rose from Rs 3,445 crore in FY22 to Rs 4,806 crore in FY26, a compound annual growth rate of 8.7%. Net profit grew from Rs 221 crore in FY22 to Rs 394 crore in FY26, which works out to a compound annual growth rate of 15.5%. In the June 2026 quarter, revenue grew 24.7% year on year to Rs 1,392 crore. The company has a return on equity of 13.6%, a debt to equity ratio of 0.34 and a market capitalisation of Rs 7,244 crore. The stock trades at a P/E of 18.4, below the industry P/E of 21.7. Looking ahead, the company is growing sustainable tube formats such as recyclable tubes, which global brands increasingly prefer. A wide plant network lets it serve large customers in many regions.
How has Vijaya Diagnostic Centre performed financially?
Ans. Revenue rose from Rs 475 crore in FY22 to Rs 835 crore in FY26, a compound annual growth rate of 15.1%. Net profit grew from Rs 111 crore in FY22 to Rs 173 crore in FY26, which works out to a compound annual growth rate of 11.8%. In the June 2026 quarter, revenue grew 22.8% year on year to Rs 240 crore, while net profit rose 37.6% to Rs 53.1 crore. The company has a return on equity of 18.1%, a debt to equity ratio of 0.44 and a market capitalisation of Rs 14,066 crore. The stock trades at a P/E of 75.0, above the industry P/E of 59.6. Looking ahead, the plan is to deepen its network in existing clusters and extend the Vijaya brand into new regions, adding imaging modalities and wellness packages that raise revenue per patient. Diagnostics is a fragmented business, so organised chains with strong brands keep gaining share.
What risks should investors check before buying FMCG, tube packaging and diagnostics stocks?
Ans. Investors should check a few risks before buying FMCG, tube packaging and diagnostics stocks. Consumer spending. Sales follow festivals, incomes and consumer mood. Test volumes. Footfall and test mix can vary with seasons. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of FMCG, tube packaging and diagnostics stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 4 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
